AstraZeneca is buying the generic drug Nexium from the US pharmacy benefit manager, making it a cheaper alternative to the branded drug.
The deal comes as Pfizer, the world's biggest pharmaceutical company, is testing the new drug for stomach problems. The two are also trying out a similar drug, a newer formulation of omeprazole, in the US.
The US generic drug maker was given $3.5bn (£2.1bn) for its share in Nexium and $1.3bn (£0.1bn) for its US share, according to IMS Health. It will be generic copies of the branded drug by the end of the year.
But AstraZeneca says it is in talks with US drug regulators over the drug, which is known for being effective in treating heartburn and acid reflux.
Under the deal, AstraZeneca will be giving the company a 30-day supply of the drug. It is also expected to be able to sell the generic version of the drug for up to three years.
Pfizer, the world's biggest pharmaceutical company, is also getting a 30-day supply of Nexium. Pfizer had said that the product could be sold in the US by the end of the year.
AstraZeneca, the world's largest drug maker, is buying the generic version of Nexium from the US pharmacy benefit manager, making it a cheaper alternative to the branded drug.
The deal comes after a US judge ordered Pfizer to stop selling the drug, and AstraZeneca said it would give the company a 30-day supply of the drug if the deal was not allowed.
It is also looking to sell the Nexium version for up to three years.
The drug, which is used to treat gastroesophageal reflux disease (GERD), is still on the market and is expected to be sold in the US by the end of the year.
But the US Food and Drug Administration is warning that the company is in talks with the Food and Drug Administration over the drug and said it could sell the drug at an earlier discount in the US.
The drug was developed as an alternative to the branded drug omeprazole, which treats nausea. It was developed by AstraZeneca and is produced by AstraZeneca in the US.
AstraZeneca is also testing the new Nexium version for stomach problems. The company is also testing its version for GERD as well.
The Nexium version of the drug, known as Nexium 24HR, is approved by the FDA in the US and the generic version of omeprazole by the FDA in Europe, and has been approved by the US Food and Drug Administration.
The company is also testing the new drug, which is used to treat stomach ulcers.
E-mail:http://www.astrazeneca.com/news-releases/nexium-generic-new-drugs.html - - - -Click image for version of drug http://www.astrazeneca.com/news-releases/nexium-generic-new-drugs.html - - - - -AstraZeneca will also be buying the company's generic version of omeprazole from the US pharmacy benefit manager, giving the two companies an exclusive deal with the Food and Drug Administration over the drug.
AstraZeneca is buying the company's generic version of Nexium from the US pharmacy benefit manager, giving the two companies an exclusive deal with the Food and Drug Administration over the drug.AstraZeneca's Nexium version of the drug, known as Nexium 24HR, is approved by the FDA in the US and the generic version of omeprazole by the FDA in Europe, and has been approved by the US Food and Drug Administration.
The drug, which is used to treat nausea, is produced by AstraZeneca in the US and is produced by AstraZeneca in the US.
The nexium business is a significant segment of gastro-intestinal pharmaceuticals, particularly those sold under brand names like Nexium (esomeprazole) and Prilosec (warfarin).
The focus of nexium is broad, particularly for patients with heartburn, acid reflux, and gastroesophageal reflux disease (GERD). Its main product category is proton pump inhibitor (PPI), which includes Nexium, Prilosec, andway more than 60 other esomeprazole brands.
Market growth is driven by the product category, with nexium expected to hold its largest market share in 2023.
Several key factors are driving growth:
This increase in product volume is driven by increased Esomeprazole volumes, as well as a) the launch of nexium Nexium and b) the rise of other product categories within the nexium product line.
In 2023, advances in product options and new product types are being made available. These changes include the creation of nexium Nexium alternatives, the advancements in Esomeprazole product formulation, and the advancements in Nexium's product packaging.
Key factors that have a role are:
Regional variations in regulatory policies and legislativerenational measures are influencing nexium's product development and management.
Key players within the nexium product management system include:
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$35.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Stomaching and bloating is not expectedEach bottle is taxed on a first come, first private research. This restricted-use product is supplied in a 20ustainage unit. Each bottle contains 20ustainage units. Each 20ustainage unit contains 20 units of magnesium stearate.
Healthylife does not suggest that these tablets, capsules or syrups are suitable for use in children.
Healthylife does not enforce the US Food and Drug Administration's (FDA) Medication Guide or the European Medicines Agency's (EMEA) Stipulation Policies or Procedures for Generic Medicines (S4). Instead, Healthylife provides a more technical approach to providing safe and effective medicines in order to comply with various regulatory requirements.
Healthylife provides a complete list of intellectual property (IEPs) and other protections for prescription medicines. Healthylife works with suppliers to ensure that our products are safe and effective to use, and to ensure that our medicines are safe and effective to use. Healthylife also maintains intellectual property ( intellectual property) for all products sold by its brands, manufacturers and distributors.
Product InformationHealthylife provides a list of various ingredients that are used to provide safe and effective therapeutic products for managing acid reflux and other gastrointestinal problems. These ingredients include:
Alternate Name:Pharmapure RX Esomep-EZS
Description:Nexium treats gastroesophageal reflux disease (GERD), esophagitis, and stomach ulcers. The generic version of Nexium is esomeprazole magnesium. For a supply of 30 oral tablets of Nexium Delayed-Release Capsules 40 mg is approximately $287. Take advantage of our LowerMyRx discount to receive a typical Nexium discount of up to 80% off of the retail price at participating pharmacies near you.
Dosage Form:Capsule Delayed Release
Administration Route:By mouth
Drug Class:Gastric Acid Secretion Inhibitor, Gastrointestinal Agent
Generic Available:Yes
Strength:20 MG
Warnings:Tell your doctor if you are pregnant or breastfeeding, or if you have kidney disease, liver disease, lupus, vitamin B12 deficiency, or osteoporosis. This medicine may cause the following problems: Kidney problems, including acute tubulointerstitial nephritisIncreased risk of broken bones in the hip, wrist, or spine (more likely if used several times per day or longer than 1 year)Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and drug reaction with eosinophilia and systemic symptoms (DRESS)LupusFundic gland polyps (abnormal growth in the upper part of your stomach) This medicine can cause diarrhea. Call your doctor if the diarrhea becomes severe, does not stop, or is bloody. Do not take any medicine to stop diarrhea until you have talked to your doctor. Diarrhea can occur 2 months or more after you stop taking this medicine. Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments. Keep all medicine out of the reach of children. Never share your medicine with anyone. Stomach pain, nausea, vomiting, weight loss, bloody or black stools
Food Warnings:Do not use esomeprazole if you are also using medicines that contain rilpivirine., Some medicines can affect how esomeprazole works. Tell your doctor if you are using any of the following: Atazanavir, cilostazol, diazepam, digoxin, erlotinib, ketoconazole, methotrexate, mycophenolate mofetil, nelfinavir, rifampin, saquinavir, St John's wort, tacrolimus, voriconazoleBlood thinner (including clopidogrel or warfarin)Diuretic (water pill)Iron supplements, This medicine can cause diarrhea. Diarrhea can occur 2 months or more after you stop taking this medicine., Tell any doctor or dentist who treats you that you are using this medicine. This medicine may affect certain medical test results., Your doctor will check your progress and the effects of this medicine at regular visits. Keep all appointments., Keep all medicine out of the reach of children.
You can buy esomeprazole from participating pharmacies near you: Shop at mystore.com/medwatch
Stade de France Pharmacy